These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 39094754)
1. Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier. Zhang L; Jiang X; Shi J; Zhang J; Shi X; Xie Z; Chen G; Zhang H; Mu Y; Chen J; Qi S; Liu P; Liu W J Ethnopharmacol; 2024 Dec; 335():118649. PubMed ID: 39094754 [TBL] [Abstract][Full Text] [Related]
2. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor. Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008 [TBL] [Abstract][Full Text] [Related]
3. Zhang L; Hu Y; Qi S; Zhang C; Zhou Q; Zhang D; Mu Y; Zhang H; Chen G; Liu P; Chen J; Liu W Front Pharmacol; 2022; 13():965914. PubMed ID: 36339578 [TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis. Zou J; Li W; Wang G; Fang S; Cai J; Wang T; Zhang H; Liu P; Wu J; Ma Y J Ethnopharmacol; 2021 Mar; 267():113544. PubMed ID: 33152436 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice. Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431 [TBL] [Abstract][Full Text] [Related]
6. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210 [TBL] [Abstract][Full Text] [Related]
7. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters. Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024 [TBL] [Abstract][Full Text] [Related]
8. Melatonin improves cholestatic liver disease via the gut-liver axis. Liu X; Li J; Shi M; Fu J; Wang Y; Kang W; Liu J; Zhu F; Huang K; Chen X; Liu Y J Pineal Res; 2024 Jan; 76(1):e12929. PubMed ID: 38047407 [TBL] [Abstract][Full Text] [Related]
9. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress. Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice. Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367 [TBL] [Abstract][Full Text] [Related]
11. Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling. Song G; Zou B; Zhao J; Weng F; Li Y; Xu X; Zhang S; Yan D; Jin J; Sun X; Liu C; Qiu F J Ethnopharmacol; 2023 Sep; 313():116560. PubMed ID: 37149065 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078 [TBL] [Abstract][Full Text] [Related]
13. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses. Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553 [TBL] [Abstract][Full Text] [Related]
14. Wu L; Zhou J; Zhou A; Lei Y; Tang L; Hu S; Wang S; Xiao X; Chen Q; Tu D; Lu C; Lai Y; Li Y; Zhang X; Tang B; Yang S Gut Microbes; 2024; 16(1):2390176. PubMed ID: 39205654 [TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation. Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665 [TBL] [Abstract][Full Text] [Related]
17. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis. Liu J; Liu J; Meng C; Huang C; Liu F; Xia C Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478 [TBL] [Abstract][Full Text] [Related]
18. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism. Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148 [TBL] [Abstract][Full Text] [Related]
19. Caffeoylquinic acids from Silphium perfoliatum L. show hepatoprotective effects on cholestatic mice by regulating enterohepatic circulation of bile acids. Zhang G; Jia W; Liu L; Wang L; Xu J; Tao J; Xu M; Yue M; Luo H; Hai P; Yue H; Zhang D; Zhao X J Ethnopharmacol; 2025 Jan; 337(Pt 2):118870. PubMed ID: 39357582 [TBL] [Abstract][Full Text] [Related]
20. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]